
News|Articles|November 20, 2023
Data is Becoming a Differentiator for Hubs that Support Specialty Drugs
Author(s)CareMetx
In a recent study, CareMetx engaged with senior leadership at leading biopharmaceutical manufacturers, aiming to evaluate the optimal ways in which Hub data can enhance manufacturer support. These findings can serve as a valuable guide for manufacturers seeking insights on optimizing their utilization of Hub data.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine
2
Will PBMs' TrumpRx Price Pledge Reach Prescribers?
3
Report: Mail-Order Pharmacy Satisfaction Climbs as Retail Trust Slips
4
AI In Pharmacovigilance: The Commercial and Market-Access Imperative
5